UTMD logo

Utah Medical Products (UTMD) Accounts Receivable

Annual Accounts Receivable

$4.09 M
+$607.00 K+17.40%

December 1, 2024


Summary


Performance

UTMD Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherUTMDbalance sheetmetrics:

Quarterly Accounts Receivable

$4.09 M
+$375.00 K+10.08%

December 31, 2024


Summary


Performance

UTMD Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherUTMDbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

UTMD Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+17.4%+11.6%
3 y3 years-22.6%-22.6%
5 y5 years-15.3%-15.3%

UTMD Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-26.1%+17.4%-32.1%+17.4%
5 y5-year-26.1%+17.4%-32.1%+17.4%
alltimeall time-26.1%+32.4%-32.5%+32.4%

Utah Medical Products Accounts Receivable History

DateAnnualQuarterly
Dec 2024
-
$4.09 M(+10.1%)
Dec 2024
$4.09 M(+17.4%)
-
Sep 2024
-
$3.72 M(+1.4%)
Jun 2024
-
$3.67 M(+2.1%)
Mar 2024
-
$3.59 M(+3.0%)
Dec 2023
$3.49 M(-37.0%)
$3.49 M(+0.0%)
Sep 2023
-
$3.49 M(-3.2%)
Jun 2023
-
$3.60 M(-5.6%)
Mar 2023
-
$3.82 M(-31.1%)
Dec 2022
$5.54 M(+4.7%)
$5.54 M(-8.2%)
Sep 2022
-
$6.03 M(+22.2%)
Jun 2022
-
$4.94 M(-13.7%)
Mar 2022
-
$5.72 M(+8.2%)
Dec 2021
$5.29 M(+25.2%)
$5.29 M(+8.9%)
Sep 2021
-
$4.85 M(+5.4%)
Jun 2021
-
$4.61 M(+10.8%)
Mar 2021
-
$4.16 M(-1.6%)
Dec 2020
$4.22 M(-12.6%)
$4.22 M(-1.2%)
Sep 2020
-
$4.28 M(+12.8%)
Jun 2020
-
$3.79 M(-14.0%)
Mar 2020
-
$4.41 M(-8.8%)
Dec 2019
$4.83 M(+19.0%)
$4.83 M(-4.6%)
Sep 2019
-
$5.07 M(-3.2%)
Jun 2019
-
$5.24 M(+6.6%)
Mar 2019
-
$4.91 M(+20.8%)
Dec 2018
$4.06 M(+9.5%)
$4.06 M(-9.2%)
Sep 2018
-
$4.48 M(-1.2%)
Jun 2018
-
$4.53 M(+7.7%)
Mar 2018
-
$4.21 M(+13.4%)
Dec 2017
$3.71 M(+12.9%)
$3.71 M(-21.5%)
Sep 2017
-
$4.73 M(+5.7%)
Jun 2017
-
$4.47 M(+7.1%)
Mar 2017
-
$4.18 M(+27.0%)
Dec 2016
$3.29 M(-12.3%)
$3.29 M(-34.6%)
Sep 2016
-
$5.03 M(+1.1%)
Jun 2016
-
$4.98 M(-7.9%)
Mar 2016
-
$5.40 M(+44.1%)
Dec 2015
$3.75 M(-6.1%)
$3.75 M(-31.7%)
Sep 2015
-
$5.49 M(-2.1%)
Jun 2015
-
$5.61 M(+12.0%)
Mar 2015
-
$5.01 M(+25.5%)
Dec 2014
$3.99 M(+6.4%)
$3.99 M(-14.1%)
Sep 2014
-
$4.65 M(-14.7%)
Jun 2014
-
$5.45 M(+7.3%)
Mar 2014
-
$5.08 M(+35.2%)
Dec 2013
$3.75 M
$3.75 M(-24.4%)
Sep 2013
-
$4.96 M(-12.5%)
DateAnnualQuarterly
Jun 2013
-
$5.67 M(+5.8%)
Mar 2013
-
$5.36 M(+34.4%)
Dec 2012
$3.99 M(-12.9%)
$3.99 M(-20.8%)
Sep 2012
-
$5.04 M(-1.0%)
Jun 2012
-
$5.09 M(-16.1%)
Mar 2012
-
$6.07 M(+32.3%)
Dec 2011
$4.58 M(+44.9%)
$4.58 M(-8.8%)
Sep 2011
-
$5.03 M(+1.2%)
Jun 2011
-
$4.96 M(+56.9%)
Dec 2010
$3.16 M(+0.2%)
$3.16 M(+0.2%)
Dec 2009
$3.16 M(-7.2%)
$3.16 M(-7.2%)
Dec 2008
$3.40 M(-9.4%)
$3.40 M(-7.9%)
Sep 2008
-
$3.69 M(-7.6%)
Jun 2008
-
$4.00 M(-1.8%)
Mar 2008
-
$4.07 M(+8.5%)
Dec 2007
$3.75 M(+7.1%)
$3.75 M(-5.9%)
Sep 2007
-
$3.99 M(-3.2%)
Jun 2007
-
$4.12 M(-3.6%)
Mar 2007
-
$4.28 M(+22.0%)
Dec 2006
$3.51 M(+1.1%)
$3.51 M(-8.1%)
Sep 2006
-
$3.81 M(-1.6%)
Jun 2006
-
$3.88 M(-19.6%)
Mar 2006
-
$4.83 M(+39.1%)
Dec 2005
$3.47 M(-7.0%)
$3.47 M(+0.1%)
Sep 2005
-
$3.47 M(-11.9%)
Jun 2005
-
$3.94 M(+0.5%)
Mar 2005
-
$3.92 M(+5.0%)
Dec 2004
$3.73 M(+12.1%)
$3.73 M(+16.2%)
Sep 2004
-
$3.21 M(-8.3%)
Jun 2004
-
$3.50 M(+1.5%)
Mar 2004
-
$3.45 M(+3.7%)
Dec 2003
$3.33 M(+7.5%)
$3.33 M(-10.2%)
Sep 2003
-
$3.71 M(+9.4%)
Jun 2003
-
$3.39 M(+1.1%)
Mar 2003
-
$3.35 M(+8.3%)
Dec 2002
$3.09 M(-13.7%)
$3.09 M(-8.8%)
Sep 2002
-
$3.39 M(-2.0%)
Jun 2002
-
$3.46 M(-6.2%)
Mar 2002
-
$3.69 M(+2.8%)
Dec 2001
$3.58 M(-9.9%)
$3.58 M(-6.4%)
Sep 2001
-
$3.83 M(+1.0%)
Jun 2001
-
$3.79 M(+0.7%)
Mar 2001
-
$3.77 M(-5.3%)
Dec 2000
$3.98 M
$3.98 M(+8.0%)
Sep 2000
-
$3.69 M(-7.7%)
Jun 2000
-
$3.99 M(+4.4%)
Mar 2000
-
$3.82 M

FAQ

  • What is Utah Medical Products annual accounts receivable?
  • What is the all time high annual accounts receivable for Utah Medical Products?
  • What is Utah Medical Products annual accounts receivable year-on-year change?
  • What is Utah Medical Products quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Utah Medical Products?
  • What is Utah Medical Products quarterly accounts receivable year-on-year change?

What is Utah Medical Products annual accounts receivable?

The current annual accounts receivable of UTMD is $4.09 M

What is the all time high annual accounts receivable for Utah Medical Products?

Utah Medical Products all-time high annual accounts receivable is $5.54 M

What is Utah Medical Products annual accounts receivable year-on-year change?

Over the past year, UTMD annual accounts receivable has changed by +$607.00 K (+17.40%)

What is Utah Medical Products quarterly accounts receivable?

The current quarterly accounts receivable of UTMD is $4.09 M

What is the all time high quarterly accounts receivable for Utah Medical Products?

Utah Medical Products all-time high quarterly accounts receivable is $6.07 M

What is Utah Medical Products quarterly accounts receivable year-on-year change?

Over the past year, UTMD quarterly accounts receivable has changed by +$427.00 K (+11.64%)